Skip to main content
. Author manuscript; available in PMC: 2014 Aug 26.
Published in final edited form as: Otol Neurotol. 2011 Apr;32(3):428–432. doi: 10.1097/MAO.0b013e3182096dc2

Table 2.

Patients Sequentially Implant (n=7)

Implant Type Sex Side Age DOS Etiology Duration HINT CNC Electrodes
Nucleus Female Right 2/13/81 10/19/05 ECMO 1 y 94% 70% Partial ST/SV
Nucleus Female Left 2/13/81 6/28/06 ECMO 1 y 100% 86% Full ST
Nucleus Female Right 8/22/80 8/1/05 genetic 24 y 87% 20% Partial ST/SV
Nucleus Female Left 8/22/80 7/19/07 genetic 20 y 90% 20% Full ST
Nucleus Male Right 3/11/67 3/1/98 Cogan 7 y 94% 78% Full ST
Nucleus Male Left 3/11/67 7/14/08 Cogan 10 y 96% 76% Partial ST/SV
Nucleus Female Right 8/13/65 12/17/02 Genetic 32 y 63% 24% Full ST
Nucleus Female Left 8/13/65 11/24/08 Genetic 40 y 43% 30% Full ST
Nucleus Female Right 12/3/69 9/1/04 Unknown 21 y 75% 38% Partial ST/SV
Nucleus Female Left 12/3/69 1/20/10 Unknown 35 y 95% 60% Partial ST/SV
ABC Male Right 9/17/67 2/28/07 Ototoxic 39 y 22% 0% Full ST
ABC Male Left 9/17/67 9/18/08 Ototoxic 40 y 11% 0% Partial ST/SV
ABC Female Right 7/20/67 1/5/05 Genetic 3 y 94% 58% Full ST
ABC Female Left 7/20/67 8/30/07 Genetic 5 y 92% 68% Full ST